Alerts

Prostate Cancer Treatment Is Creating a Metabolic Bill
A large JAMA Oncology study found metabolic abnormalities were frequently documented within the first year after men started ADT plus androgen receptor pathway inhibitor therapy. The survival gains are real. So is the cardiometabolic debt.

Hodgkin Lymphoma Survivors Are Still Paying for Cure

Sanfilippo’s Approval Path Is Being Built Before Approval

Pertussis Rose. The Definition Amplified It.

Parkinson’s Gets a Cleaner Dopamine Bet

Europe Made Genomics Mandatory.

Cardiac rehabilitation is now explicitly personalised in Europe. Reimbursement could decide who gets it

Endometrial Cancer Prehab Should Not Be a Luxury Experiment

Bladder Cancer Is Moving Into the Immunotherapy Maintenance Era

Duchenne’s Cell Therapy Gets More Time, Not Certainty
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
